REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/04/2026
Voltar para busca
Dado oficial do USPTO
LIFELABS GENETICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000087246841Classe
1, 5, 9, 35, 38, 42, 44
Pedido
87246841
Registro
6311559
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
76
Atualização mais recente
07/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 9, 35, 38, 42, 44
Data de depósito
23/11/2016
Data de registro
06/04/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/04/2021
Última transação
07/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
13
Localização do titular
Toronto, Ontario, CA
Examinador
GARDNER, DAWNA BERYL
Unidade examinadora
M80
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "LIFELABS" above the stylized wording "GENETICS". The letter "I" in "LIFE" is composed of a stylized stick person with a dot for a head. The letter "I" in "GENETICS" is a letter "I" inside of a circle.
Titulares e representantes
Titulares
L. L. (pessoa física)
Representantes
Nicholas G. de la Torre Neal & McDevitt, LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 35Classe 38Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
chemically treated non-medical test strips for calibration of laboratory test equipment and medical diagnostic equipment; diagnostic preparations for medical laboratory use; diagnostic reagents for clinical and medical laboratory use; assays and reagents for use in genetic research; genetic identity tests comprised of reagents for non-medical purposes; reagents for scientific or medical research use; chemical reagents for non-medical purposes
Classe 5
drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids for the presence of lipidscarbohydratesproteinsenzymesacidsalcoholsmetabolitesvitaminselectrolytesheavy metalscontaminantspoisonstoxins; diagnosticpreparations for medical research use; medical diagnostic reagents; diagnostic kits comprised of organic and inorganic medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; biological preparations for detecting genetic predispositions for medical purposes; newborn screeningsgenetic identity tests comprised of reagents for medical purposes; newborn screeningspreparations for detecting somatic mutation in genes for medical purposes; newborn screeningspreparations for detecting autoimmune diseases in genes for medical purposes; newborn screeningspreparations for detecting epigenetic disorders in genes for medical purposes; newborn screeningsmedical diagnostic test strips for blood analysis; diagnostic biomarker reagents for analysis of genetic sequencing for medical purposes; diagnostic biomarker reagents for analysis of metabolic disorders for medical purposes; diagnostic biomarker reagents for analysis of enzyme deficiency for medical purposes
Classe 9
Aliquottersmanual and robotic devices for use in medical laboratories to accurately dispense liquid volumes of medical patient samples and reagents into separate specimen containers; filters for blood and blood components for laboratory use; laboratory devices implementing nucleic acid extractionfluorescence in situ hybridization and competitive hybridization to detect genetic sequences; scientific instrumentsanalyzers for detecting and karyotyping chromosomes; computer software for scientific analysis of genetic sequences; computer software platform for analyzing bioinformatics to interpret results of genetic testing; computer software platforms for use in generating clinical reports for genetic testing; computer communications software for connecting medical practices via the Internet to manage and share patient information relating to genetic testing orders and results; computer programs for managing requests for genetic testinglaboratory processing and laboratory equipment; computer programs for controlling quality of testing and integrity of testing results
Classe 35
data processing services; customer servicesresponding to customers inquiries for others in the field of medical laboratory services; customer servicesresponding to customers inquiries for others in the field of medical diagnostic services
Classe 38
providing access to an electronic exchange of medical records across a nationwide health information network to enable physicians to make informed medical recommendations
Classe 42
medical research consulting; design and development of computer hardware and software for genetic testinggenetic sequencingbiochemical analysisnewborn screening and data processing; laboratory research in the fields of biochemistry and medical genetics; laboratory testing of materials; medical laboratory services; blood analysis services; DNA analysis services for scientific research purposes; providing medical research information in the field of patient clinical trials; providing an interactive web site featuring technology that enables users to accessmonitor and generate medical information and reports; providing information relating to pharmacology consultancy
Classe 44
consulting services in the field of genetic testing for medical purposes; consulting services in the field of medical testing for diagnostic purposes; consulting services in the field of medical screening of infants for hereditary medical disorders; medical analysis services for diagnostic and medical purposesmedical analysis ofbloodbody fluidsextracellular tissue specimensstool samplesexhaled airbiopsy specimens and autopsy specimens; Medical laboratory testing of bloodbody fluidsextracellular tissue specimensstool samplesexhaled airbiopsy specimens and autopsy specimens all for diagnostic and medical purposes; medical information servicesreporting of patient authorized clinical testing results directly to doctors; medical analysis services of patient medical data for the diagnosis of cancer; providing medical information to doctors in the form of reports in the field of a medical diagnosis; providing healthcare information; providing medical information to patients in the field of pharmaceutical treatments; providing information relating to diagnostic properties of pharmaceuticals; providing medical information; providing health information to physicians about surgical instruments
Publicações
Histórico de despachos e eventos da marca no USPTO.
76 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/03/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
27/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/04/2021
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
04/03/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/03/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
22/11/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
22/11/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
29/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/08/2020
PUBO
PUBLISHED FOR OPPOSITION
04/08/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/07/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
26/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/12/2019
GNRT
NON-FINAL ACTION E-MAILED
19/12/2019
CNRT
NON-FINAL ACTION WRITTEN
19/12/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
14/12/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/12/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/06/2019
GNRT
NON-FINAL ACTION E-MAILED
12/06/2019
CNRT
NON-FINAL ACTION WRITTEN
12/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/05/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/04/2019
GNRT
NON-FINAL ACTION E-MAILED
26/04/2019
CNRT
NON-FINAL ACTION WRITTEN
26/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/03/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
27/03/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
26/03/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
28/09/2018
GNSI
INQUIRY TO SUSPENSION E-MAILED
28/09/2018
CNSI
SUSPENSION INQUIRY WRITTEN
28/09/2018
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
27/09/2018
ALIE
ASSIGNED TO LIE
27/09/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/03/2018
GNSL
LETTER OF SUSPENSION E-MAILED
07/03/2018
CNSL
SUSPENSION LETTER WRITTEN
07/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/02/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/02/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
13/02/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/11/2017
GNSL
LETTER OF SUSPENSION E-MAILED
07/11/2017
CNSL
SUSPENSION LETTER WRITTEN
07/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/10/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
16/10/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
22/09/2017
GNSL
LETTER OF SUSPENSION E-MAILED
22/09/2017
CNSL
SUSPENSION LETTER WRITTEN
22/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/09/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/03/2017
GNRT
NON-FINAL ACTION E-MAILED
09/03/2017
CNRT
NON-FINAL ACTION WRITTEN
09/03/2017
DOCK
ASSIGNED TO EXAMINER
01/03/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/12/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/12/2016
NWAP
NEW APPLICATION ENTERED
26/11/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LIFELABS GENETICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.